CeriBell (NASDAQ:CBLL) Shares Gap Down Following Weak Earnings

CeriBell, Inc. (NASDAQ:CBLL) shares gapped down before the market opened on Tuesday following a weaker than expected earnings announcement. The stock had previously closed at $20.06, but opened at $18.54. CeriBell shares last traded at $16.5950, with a volume of 88,801 shares trading hands.

The company reported ($0.52) EPS for the quarter, missing the consensus estimate of ($0.39) by ($0.13). CeriBell had a negative net margin of 59.97% and a negative return on equity of 31.77%. The firm had revenue of $26.49 million during the quarter, compared to the consensus estimate of $26.09 million.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on the stock. Weiss Ratings reissued a “sell (d-)” rating on shares of CeriBell in a report on Monday, April 6th. BTIG Research reissued a “buy” rating and issued a $30.00 target price on shares of CeriBell in a research note on Wednesday, January 28th. Finally, Canaccord Genuity Group set a $25.00 price target on CeriBell in a research note on Tuesday. One investment analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $22.20.

Insiders Place Their Bets

In other CeriBell news, VP David Foehr sold 4,560 shares of the firm’s stock in a transaction dated Tuesday, March 3rd. The shares were sold at an average price of $17.80, for a total value of $81,168.00. Following the completion of the sale, the vice president directly owned 17,550 shares in the company, valued at $312,390. This trade represents a 20.62% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. Also, CTO Raymond Woo sold 11,112 shares of CeriBell stock in a transaction that occurred on Wednesday, April 1st. The shares were sold at an average price of $18.56, for a total value of $206,238.72. Following the sale, the chief technology officer directly owned 166,912 shares in the company, valued at approximately $3,097,886.72. The trade was a 6.24% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders sold 175,119 shares of company stock worth $3,310,772. 20.10% of the stock is currently owned by company insiders.

Institutional Trading of CeriBell

A number of hedge funds and other institutional investors have recently modified their holdings of the business. Russell Investments Group Ltd. increased its stake in shares of CeriBell by 41.4% in the 4th quarter. Russell Investments Group Ltd. now owns 2,918 shares of the company’s stock worth $64,000 after acquiring an additional 854 shares in the last quarter. Caitong International Asset Management Co. Ltd raised its holdings in CeriBell by 3,971.0% in the fourth quarter. Caitong International Asset Management Co. Ltd now owns 1,262 shares of the company’s stock worth $28,000 after buying an additional 1,231 shares during the last quarter. Deutsche Bank AG lifted its position in CeriBell by 1.7% in the 4th quarter. Deutsche Bank AG now owns 85,182 shares of the company’s stock valued at $1,868,000 after acquiring an additional 1,393 shares in the last quarter. Strs Ohio bought a new position in shares of CeriBell during the first quarter valued at $27,000. Finally, Royal Bank of Canada lifted its stake in CeriBell by 10.8% during the 4th quarter. Royal Bank of Canada now owns 15,588 shares of the company’s stock valued at $342,000 after acquiring an additional 1,514 shares during the period.

CeriBell Price Performance

The stock has a market capitalization of $631.10 million, a PE ratio of -11.34 and a beta of 0.99. The firm’s fifty day moving average price is $19.21 and its two-hundred day moving average price is $18.81. The company has a quick ratio of 9.35, a current ratio of 9.73 and a debt-to-equity ratio of 0.13.

CeriBell Company Profile

CeriBell Corp (NASDAQ: CBLL) is a healthcare technology company specializing in the design, manufacture and sale of automated newborn hearing screening devices. The company offers a suite of medical diagnostic tools based on otoacoustic emissions (OAE) and auditory brainstem response (ABR) technologies, enabling early detection of auditory impairments in infants. CeriBell’s solutions are used in hospitals, birthing centers and audiology clinics to support universal newborn hearing screening programs aimed at improving language development outcomes through prompt intervention.

The company’s product portfolio includes handheld and desktop screening units, proprietary software for data management, and accessories designed to streamline testing workflows.